Fundraising Fox

Istari Oncology

Morrisville, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

MB
Marc BanjakExecutive
MW
Matthew W. FarberExecutive
WG
William G. NicholsExecutive
MR
Matthew R. StoberExecutive

Board

RB
Robert BonczekBoard director
RC
Raymond CheongBoard director
VS
Victor SandorBoard director
SN
Sean NolanBoard director
DP
Dani P. BolognesiBoard director

Investors · 1

Pappas CapitalDurham

Reported raises · per SEC filings

Form D private placements

$48.6M disclosed across 3 rounds · 2017–2021

▶$43.5MraisedApr 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert BonczekDirector
  • Raymond CheongDirector
  • Marc BanjakExecutive Officer
  • Matthew W. FarberExecutive Officer
  • William G. NicholsExecutive Officer
  • Victor SandorDirector
  • Sean NolanDirector
  • Matthew R. StoberExecutive Officer, Director
  • Dani P. BolognesiDirector
Offering amount
$70M
Amount sold
$43.5M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMay 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert BonczekExecutive Officer, Director
  • Dani P. BolognesiExecutive Officer, Director
  • Henry FriedmanExecutive Officer
  • Timothy J. CreechExecutive Officer
  • Darell D. BignerDirector, Promoter
Offering amount
$4M
Amount sold
$1.1M
First sale
May 2017
Incorporated
Corporation, North Carolina, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedFeb 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Darell D. BignerExecutive Officer, Director, Promoter
  • Timothy J. CreechExecutive Officer
  • Dani P. BolognesiExecutive Officer, Director
  • Henry FriedmanExecutive Officer
  • Robert BonczekExecutive Officer, Director
Offering amount
$4M
Amount sold
$4M
First sale
Jan 2017
Incorporated
Corporation, North Carolina, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Startup Spotlight: Istari Oncology enters agreement with FUJIFILM Diosynth Biotechnologies | WRAL TechWirewraltechwire.com · Nov 2021Istari Oncology Enters Into Manufacturing Agreement With FUJIFILM Biotechnologies to Advance its Viral Immunotherapy PVSRIPO - FUJIFILM Biotechnologiesfujifilmbiotechnologies.fujifilm.com · Oct 2021Duke spin-out Istari Oncology raises stakes for polio-based cancer treatment - Triangle Business Journalbizjournals.com · Aug 2021Morrisville North Carolina based Istari Oncology is raising $70,000,000.00 in New Equity Investment. - intelligence360intelligence360.news · Jun 2021Istari Oncology, now with FDA clearance for PVSRIPO, raises $43.4M | WRAL TechWirewraltechwire.com · Apr 2021Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy for PVSRIPO in Patients with Advanced Solid Tumors - BioSpacebiospace.com · Apr 2021

Frequently asked questions

Who are Istari Oncology's investors?
Istari Oncology's investors include Pappas Capital.
How much funding has Istari Oncology raised?
Istari Oncology has disclosed $48.6M raised across 3 rounds.
Where is Istari Oncology headquartered?
Istari Oncology is headquartered in Morrisville, US.